| Abbreviation | Definition |
| DDS | Drug delivery system |
| PAE | Poly(amino ester) |
| IV | Intravenous |
| 5-ALA | 5-Aminolevulinic |
| CC | Colon cancer |
| CB | Cathepsin B |
| HA | Hyaluronic acid |
| Cy5.5 | Cyanine 5.5 |
| IRT | Irinotecan |
| PFH | Perfluorohexane |
| DOX | Doxorubicin |
| GdNGs | Gadolinium nanogels |
| MRI | Magnetic resonance imaging |
| NIR | Near infrared |
| C6 | Chlorine 6 |
| PTX | Paclitaxel |
| FA | Folic acid |
| PHEMA | Poly(2-hydroxyethyl Methacrylate) |
| HEMA | 2-Hydroxyethyl methacrylate |
| TPGDA | Tripropyleneglycol diacrylate |
| PNIPAAm | Poly(N-isopropyl acrylamide) |
| LCST | Lower critical solution temperature |
| AAc | Acrylic acid |
| PAA | Poly(allyl amine) |
| PEI | Poly(ethylenimine) |
| BPEI | Branched poly(ethylenimine) |
| QDs | Quantum dots |
| FD | Fucoidan |
| TMC | Trimethyl chitosan |
| TCD | Tetracyclododecene |
| CMC | Critical micelles concentration |
| FAPPI | Folate acid conjugated poly(propylene imine) |
| MTX | Methotrexate |
| XG | Xanthan gum |
| DCT | Docetaxel |
| PLGA | poly(D,L-lactide-co-glycolide) |
| HACE | HA acid–ceramide |
| PLA | Poly(lactic acid) |
| PEO | Poly(ethylene oxide) |
| PPO | Poly(propylene oxide) |
| RES | Reticuloendothelial system |
| ABC | Accelerated blood clearance |
| P-gP | P-glycoprotein |
| IP | Intraperitoneal |
| PNVP | Poly(N-vinyl pyrrolidone) |
| BBB | Blood-brain barrier |
| CNS | Central nervous system |
| EVs | Extracellular vesicles |
| MSCs | Mesenchymal stem cells |
| MVBs | Multivesicular bodies |